Does NLRP3 gene silencing ameliorate diabetic cardiomyopathy in a type 2 diabetes rat model?
Background: Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome is associated with metabolic disorder and cell death, which are important triggers in diabetic cardiomyopathy (DCM). We aimed to explore whether NLRP3 inflammasome activation contributes to DCM and the mechanism involved.
Luo et al. (Tue,) studied this question.